Field & Main Bank Biogen Inc. Transaction History

Field & Main Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 07, 2019	SELL	$217.44 - $243.88 $16,308 - $18,291	-75 Closed	0 $0
Q1 2019 Apr 24, 2019	SELL	$216.71 - $338.96 $5,417 - $8,474	-25 Reduced 25.0%	75 $18,000
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $51,504 - $61,382	-200 Reduced 66.67%	100 $33,000
Q4 2017 Jan 24, 2018	BUY	$307.64 - $344.58 $92,292 - $103,374	300	300 $96,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Field & Main Bank, based on Form 13F filings with the SEC.

Stay updated on Field & Main Bank with notifications on news.